Chavez-Reyes A - Search Results

1

Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice.

Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El-Naggar AK, Multani A, Chang S, Lozano G. Liu G, et al. Nat Genet. 2004 Jan;36(1):63-8. doi: 10.1038/ng1282. Epub 2003 Dec 21. Nat Genet. 2004. PMID: 14702042 Free article.

2

Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality.

Montes de Oca Luna R, Amelse LL, Chavez-Reyes A, Evans SC, Brugarolas J, Jacks T, Lozano G. Montes de Oca Luna R, et al. Nat Genet. 1997 Aug;16(4):336-7. doi: 10.1038/ng0897-336. Nat Genet. 1997. PMID: 9241268 No abstract available.

3

Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null mice.

McDonnell TJ, Montes de Oca Luna R, Cho S, Amelse LL, Chavez-Reyes A, Lozano G. McDonnell TJ, et al. J Pathol. 1999 Jul;188(3):322-8. doi: 10.1002/(SICI)1096-9896(199907)188:3<322::AID-PATH372>3.0.CO;2-F. J Pathol. 1999. PMID: 10419603

4

Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.

Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG, Lozano G. Parant J, et al. Nat Genet. 2001 Sep;29(1):92-5. doi: 10.1038/ng714. Nat Genet. 2001. PMID: 11528400

5

Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets.

Chavez-Reyes A, Parant JM, Amelse LL, de Oca Luna RM, Korsmeyer SJ, Lozano G. Chavez-Reyes A, et al. Cancer Res. 2003 Dec 15;63(24):8664-9. Cancer Res. 2003. PMID: 14695178

6

HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells.

Tuna M, Chavez-Reyes A, Tari AM. Tuna M, et al. Oncogene. 2005 Feb 24;24(9):1648-52. doi: 10.1038/sj.onc.1208345. Oncogene. 2005. PMID: 15674342

7

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, Merritt WM, Jennings NB, Chavez-Reyes A, Coleman RL, Gershenson DM, Schmandt R, Cole SW, Lopez-Berestein G, Sood AK. Halder J, et al. Clin Cancer Res. 2006 Aug 15;12(16):4916-24. doi: 10.1158/1078-0432.CCR-06-0021. Clin Cancer Res. 2006. PMID: 16914580 Free PMC article.

8

Murine interferon-gamma inducible protein-10 (IP-10) secreted by Lactococcus lactis chemo-attracts human CD3+ lymphocytes.

Villatoro-Hernandez J, Arce-Mendoza AY, Rosas-Taraco AG, Esparza-González SC, Guzmán-López S, Elizondo-Omaña RE, Chávez-Reyes A, Saucedo-Cárdenas O, de Oca Luna RM. Villatoro-Hernandez J, et al. Biotechnol Lett. 2009 Nov;31(11):1795-800. doi: 10.1007/s10529-009-0081-7. Epub 2009 Jul 18. Biotechnol Lett. 2009. PMID: 19618273

9

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK. Landen CN Jr, et al. Cancer Res. 2005 Aug 1;65(15):6910-8. doi: 10.1158/0008-5472.CAN-05-0530. Cancer Res. 2005. PMID: 16061675

10

c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.

Vivas-Mejia P, Benito JM, Fernandez A, Han HD, Mangala L, Rodriguez-Aguayo C, Chavez-Reyes A, Lin YG, Carey MS, Nick AM, Stone RL, Kim HS, Claret FX, Bornmann W, Hennessy BT, Sanguino A, Peng Z, Sood AK, Lopez-Berestein G. Vivas-Mejia P, et al. Clin Cancer Res. 2010 Jan 1;16(1):184-94. doi: 10.1158/1078-0432.CCR-09-1180. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters